STRAMSEN BIOTECH, INC
Invest with us
Stramsen Biotech Inc. is proud to offer an exceptional investment opportunity to a diverse range of investors, including individuals, hedge funds, and venture capitalists. As we approach the final stages of our Regulation A offering approval process, we're excited to announce that we're currently raising funds through a Regulation D offering. To ensure a seamless and professional investment experience, we've partnered with a prestigious broker-dealer to facilitate capital raising for both our Regulation A and Regulation D offerings.
​
​​Stramsen Biotech Inc is proudly backed by its lead investor, GEM Global Yield LLC SCS, a multi-billion dollar private equity firm. This strategic partnership underscores our company's immense potential and positions us at the forefront of biopharmaceutical innovation.
​
Seize this extraordinary opportunity with Stramsen Biotech Inc.! We're offering an unprecedented, limited-time discount of approximately 86% for Reg A investors, reducing the share price to an astounding $1.20. This exceptional offer has the potential to increase your private assets by an impressive 623% based on a single investment purchase.
​
For Reg D investors, we're presenting an even more compelling proposition: a remarkable 91% discount, bringing the share price down to just $0.80. This could potentially boost your private assets by an extraordinary 983% with a single share purchase. Don't miss out on this game-changing investment opportunity!
​
Stramsen Biotech Inc. is currently valued at an impressive $6.5 billion, with a regular share price of $8.67. By investing now at these significantly discounted rates, you're positioning yourself for potentially substantial returns as we continue to revolutionize the biopharmaceutical industry with our innovative, plant-based approach to medicine.
​
Act now to secure your stake in the future of healthcare. With Stramsen Biotech Inc., you're not just investing in a company; you're investing in a vision that could transform countless lives. Don't let this unparalleled opportunity slip away!
​
In a strategic move to enhance our investor relations and capital management capabilities, Stramsen Biotech Inc. has forged a powerful alliance with Nasdaq Private Market, a specialized division of the renowned Nasdaq exchange. This New York-based broker-dealer excels in facilitating transactions in both private secondary and primary markets, providing unparalleled opportunities for the sale of company and shareholders' shares. This partnership not only streamlines our ability to connect with potential investors but also empowers us to manage our capital structure with unprecedented efficiency.
​
We invite you to be part of our groundbreaking journey in plant-based drug development. To explore the exciting investment opportunities with Stramsen Biotech Inc., please reach out to our esteemed Management team:
​
-
Office Direct
Phone: 713-955-1156​
​
-
Email: info@stramsenbiotech.com
​
-
Direct CEO contact:
​
​At Stramsen Biotech Inc., we are committed to nurturing strong, transparent relationships with our investors. Our dedicated team stands ready to provide you with comprehensive insights into our innovative plant-based drug development pipeline and the transformative potential it holds. Don't miss this chance to be part of a revolution in pharmaceutical development – contact us today to learn how you can contribute to and benefit from our vision for a healthier future.
​
Homepage - Nasdaq Private Market
​
​